Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

This study has been completed.
Sponsor:
Collaborator:
Radiation Therapy Oncology Group
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT01364064
First received: May 31, 2011
Last updated: February 24, 2016
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)